Popular Articles

Workshop Develops Research Roadmap For Focused Ultrasound Treatment Of Brain Disorders
The primary objective of this workshop was to develop a comprehensive R&D roadmap that would fast-track the use of focused ultrasound technology to treat a variety of brain disorders including benign and malignant tumors, Parkinson"s disease and essential tremor, stroke, and epilepsy.
generic viagra online
Healthcare Locums Sees Demand Rocket As Trusts Prepare For European Working Time Directive
Healthcare Locums (HCL), the UK"s largest specialist health and social care agency, says it is seeing rocketing demand for locum and permanent placement doctors from Trusts struggling to prepare for the European Working Time Directive, which limits the number of hours trainee doctors can work to 48 per week.
plastic surgery before after
News of the day
MacroGenics And Lilly Achieve Targeted Patient Enrollment In PROTEGE, A Global Phase 2/3 Clinical Trial Of Teplizumab In Type 1 Diabetes
MacroGenics, Inc. and Eli Lilly and Company (NYSE: LLY) announced that the PROTEGE trial achieved its targeted patient enrollment. The trial is a pivotal Phase 2/3 clinical study evaluating teplizumab, an investigational compound under development for the treatment of individuals with recent-onset type 1 diabetes.
Oncology

Study: Breastfeeding May Reduce Likelihood Of Postpartum MS Attacks

Annette Langer-Gould, MD, PhD (Stanford University) and colleagues followed 32 pregnant women with MS, assessing their disease and breastfeeding status at intervals out to 12 months after giving birth. They found that women who breastfed their babies exclusively (without giving supplemental bottles) for at least the first two months post-partum were less likely to have an MS relapse than those who did not breastfeed or who did not breastfeed exclusively during the first two months (36% who breastfed exclusively experienced a relapse, as compared to 87% who did not breastfeed or who supplemented with formula). This pilot study, funded largely by the National Institutes of Health, was presented at the 2009 American Academy of Neurology meeting and was published early online in the Archives of Neurology on June 8, 2009. While the study is small, it focuses attention on a quandary facing women with MS and their doctors: the crucial time period after giving birth, when there is a higher risk for relapse, and many women are advised to go back on their disease-modifying therapies as soon as possible. Since there is insufficient evidence to support the safety of breastfeeding while using any of these therapies, most babies born to moms with MS are bottle fed, despite known health benefits of breastfeeding for infants. More research is needed to help guide postpartum treatment decisions. Read more about pregnancy and reproductive issues in MS National Multiple Sclerosis Society


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):